Post Profile

Bigfoot Biomedical is developing an automated insulin delivery system, which will begin pivotal trials later this year or early next year consisting of 3-month home trials first in adults, then in children. President and CEO Jeffrey Brewer, a d-dad himself, talks about the system on the Juicebox Podcast saying this “decision support system helps get […]read more

share

Related Posts

Capillary Biomedical, Inc. is getting funding support from JDRF to optimize infusion catheter in order to help people with diabetes on insulin pumps and future continuous subcutaneous insulin infusion (CSII) technology get better re...

By Adam Brown and Brian Levine Six systems expected by 2019, plus an FAQ! Which system is right for me? When JDRF started the Artificial Pancreas Project in 2006, the idea of automating insulin delivery using a standard insulin pum...

The story of a closed loop artificial pancreas company and where it hopes to go… Bigfoot Biomedical is a company dedicated to the development of a closed loop insulin delivery system. Founded and run by the parents and loved ones of...

Bigfoot Biomedical, Inc. has enrolled the first patients in a clinical trial for their Bigfoot Smartloop automated closed loop insulin delivery system. Bigfoot Biomedical is led by a team of three men, all fathers to boys living wit...

Bigfoot Biomedical, Inc announces that they have raised a Series A investment of $35.5 million in support of their efforts to complete development of their highly anticipated Smartloop automated insulin delivery system. Jeffrey Brew...